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A rare case of dengue encephalopathy 
complicating a term pregnancy
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Abstract 
Background: Dengue fever has an expanded clinical spectrum ranging from an asymptomatic infection to life 
threatening dengue hemorrhagic fever and refractory shock. Dengue infection in pregnancy can be a diagnostic 
dilemma, particularly considering the physiological changes in pregnancy and the obstetric complications encoun-
tered in clinical practice. Hence the knowledge of its diagnosis and management in its atypical presentations is of 
paramount importance. Here we report an unusual case of uncomplicated dengue encephalopathy in a term mother, 
probably the first to be reported from the Indian subcontinent.
Case Presentation: A 28 year old woman, 37 weeks of pregnancy presented with fever of four days duration. She 
eventually developed irritability, altered sensorium, somnolence, and unresponsiveness to commands by the 5th 
day of febrile illness without any circulatory compromise. Physical examination and investigations including serology 
confirmed dengue fever. After excluding all other possible causes, the transient neurological deterioration was finally 
attributed to dengue encephalopathy which is an uncommon manifestation of the disease, particularly in pregnancy. 
Her deteriorated neurological status which had lasted for 6 days improved spontaneously with the convalescence of 
dengue infection. Cautious fluid management was carried out in correlation to clinical and hematological parameters. 
The pregnancy was continued uncomplicated till the platelet count had risen to more than 50,000 cells/cumm. She 
delivered vaginally a healthy male baby.
Conclusions: Dengue fever in pregnancy is increasingly being encountered due to its rising disease burden. Dengue 
encephalitis/encephalopathy must be suspected in the differential diagnosis of fever and altered sensorium, even in 
pregnancy, in the tropical countries where the infection is rampant. Management of dengue infection in term preg-
nancy is a challenge for both the clinician and obstetrician. Further discussion and research are mandatory to decide 
on optimal management of these patients, with regard to monitoring, fluid management, and the precise timing and 
mode of delivery in order to prevent fatal morbidity and mortality to both mother and fetus.
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Background
Dengue is an mosquito-borne infection, caused by fla-
vivirus serotypes (I–IV). It represents a significant bur-
den of disease in the tropics, the global incidence is 
rising [1]. Dengue infection is a self limiting infection 
which may manifest with a spectrum of disease ranging 
from an uncomplicated febrile illness to various hemor-
rhagic manifestations and refractory shock. According 
to the world health organization dengue haemorrhagic 
fever is based on fever, thrombocytopenia and evidence 
of plasma leakage. Plasma leakage is confirmed in the 
presence of hemoconcentration (haematocrit rises 20% 
higher than the baseline) or any clinical evidence of 
bleeding.
Atypical manifestations in dengue are less recognized 
especially in a dengue epidemic situations [2]. Neurologi-
cal involvement is one such example. Various neurologi-
cal manifestations have been reported in literature [3]. 
These include encephalopathy, encephalitis, meningitis, 
myelitis, Guillain–Barre syndrome, myositis, optic neuri-
tis to name a few. A typical neurological manifestations 
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of dengue, particularly in pregnancy lacks a distinctive 
clinical picture and leads to diagnostic difficulties and 
poses a challenge to both the clinician and obstetrician. 
A high index of suspicion is mandatory in such clinical 
scenarios. We report a rare occurrence of a reversible 
dengue encephalopathy in a term mother with unevent-
ful recovery.
Case presentation
A 28 year old woman, 37 weeks of pregnancy presented 
with fever of four days duration to the casualty medi-
cal ward. The following day she appeared to be irritable, 
somnolent, aggressive and thereafter followed by unre-
sponsiveness to commands. On examination she was 
febrile, anicteric and not pale. She was confused, poorly 
responsive and her GCS was 9 (eyeopening =  2, verbal 
response = 2, motor response = 5). Respiratory, cardio-
vascular and abdominal examinations were unremark-
able. There was no neck stiffness, Kernigs and Brudzinki 
signs were negative. Cranial nerves were intact. Pyrami-
dal and extrapyramidal signs were absent. Dilated fun-
doscopy did not reveal any papilledema. Her full blood 
count revealed an isolated thrombocytopenia. White cell 
count 9000 cells/cumm, Hemoglobin 10 g/dl, mean cor-
puscular volume 85 ft, Platelets 60,000 cells/mm, counts 
progressively dropping up until 8000 cells/cumm. Hema-
tocrit was stable at 33%. ESR was 20 mm/h and was CRP 
4  mg/dL. LDH was <200  u/L. Blood picture revealed a 
thrombocytopenia in keeping with a possible viral infec-
tion, there were no features of microangiopathic hemo-
lytic anemia. Urine analysis excluded proteinuria and 
hematuria. Hepatic profile which was initially normal 
started to escalate. Aspartate aminotransferase 25 U/L up 
till 250 U/L (<40 U/L), alanine aminotransferase 20 U/L 
up till 250 U/L (<40 U/L), alkaline phosphatase 300 U/L 
(30–300 U/L) and serum bilirubin 0.7 mg/dL respectively, 
revealing an anicteric hepatitis which is a common find-
ing in dengue infection. Renal functions and serum elec-
trolytes were normal. Clotting profile was PT 10S, APTT 
38S, INR 1.2 and FDP < 0.2 u/L, excluding the possibil-
ity of disseminated intravascular coagulation. Ultrasound 
scan did not reveal any pleural effusions or ascites exclud-
ing the early signs of capillary vascular leakage. Den-
gue non structural protein-1(NS) antigen was positive at 
day 4 of the illness. Dengue IgM antibodies were high in 
titre by day 6. Due to deterioration of clinical status she 
was transferred to intensive care unit for closer observa-
tion. An electroencephalography revealed bilateral rhyth-
mic delta wave activity consistent with a diffuse cerebral 
dysfunction. CSF analysis was not performed due to pro-
found thrombocytopenia, thus making it difficult for us 
to exclude other encephalitic pathogens as a cause for the 
encephalopathy. Nevertheless since serology was strongly 
positive for dengue infection and with the present den-
gue epidemic in our country we strongly suspected den-
gue encephalopathy as our first differential diagnosis. A 
CT scan of head was not performed due to possible risk 
of radiation to the fetus and the patients relatives refused 
consent for any imaging modalities. She was monitored 
closely, careful fluid management according to guidelines 
were carried out with regular fetal monitoring and bleed-
ing precautions were undertaken. With the gradual rise 
in platelets, the patients neurological status improved 
spontaneously by day 10 of the illness. The encephalopa-
thy had lasted approximately for 6 days. Fortunately, she 
did not have any clinical evidence of increased vascular 
permeability suggestive of dengue hemorrhagic fever 
or go into dengue shock syndrome. Once the platelet 
reached 70,000/mm3, she was induced for labour and 
delivered vaginally the baby without any peripartum or 
postpartum complications.
Discussion
Neurological manifestations are uncommon in den-
gue infection. Encephalopathy is an unusual neurologi-
cal complication of dengue fever. Its incidence ranges 
between 0.5 and 6%. Several studies report that DEN-2 
and DEN-3 have the highest predisposition to neuro-
logical complications. The possible pathogenesis being 
described in literature include hepatic encephalopathy, 
cerebral hypoperfusion in dengue shock syndrome, cer-
ebral edema due to increased vascular permeability, 
deranged electrolytes, and intracranial bleeding due to 
thrombocytopenia or coagulopathy [3–6]. The infection 
causes activation of cytokines and complements which 
result in endothelial dysfunction, platelet dysfunction 
and consumptive coagulopathy.
Dengue virus was primarily thought to be a non-neu-
rotropic virus [7]. However, recent studies reveal the 
direct neuronal infiltration by the virus and the pos-
sible neurotropism leading to dengue encephalopathy 
and encephalitis. There are reports of demonstration of 
dengue virus and IgM antibody in the CSF of very few 
patients with encephalopathy/encephalitis [8, 9]. Virus 
or antibody can be isolated from the serum nevertheless 
CSF samples may be negative. In the case of our patient, 
we were unable to confirm the direct neuronal invasion 
with a CSF study due to profound thrombocytopenia, a 
strong limiting factor in confirming the diagnosis. Brain 
imaging modalities have shown a bilateral thalamic pre-
disposition in dengue encephalitis [10]. However MRI 
findings in dengue fever have not been very clearly 
explained due to the paucity of the condition. Interest-
ingly, Japanese encephalitis virus which closely resemble 
dengue virus characteristically produces bilateral tha-
lamic involvement, hence being an important differential 
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in the workup of the diagnosis [10] and can be confirmed 
by a CSF study. Though initially there was uncertainty 
about dengue encephalitis as an entity, it is established 
that dengue virus has neuroinvasive potential. The inter-
national encephalitis consortium has recognized this as 
an emerging area of encephalitis [11].
The diagnosis and management of dengue fever in 
pregnancy is a challenge to the clinician and the obste-
trician. The physiological changes in pregnancy, preg-
nancy related complications and medical disorders 
must be kept in mind before interpreting the laboratory 
values. The entities in pregnancy that resemble dengue 
fever and need to be excluded include Idiopathic throm-
bocytopenic purpura (ITP) complicated with an intrac-
ranial haemorrhage, systemic lupus erythematosus 
(SLE) with cerebral vasculitis, antiphospholipid anti-
body syndrome (APLS) with CNS complications and 
pregnancy related complications such as pre-eclamp-
sia, hemolysis, elevated liver enzymes and low plate-
lets (HELLP), thrombotic thrombocytopenic purpura 
(TTP), sepsis and disseminated intravascular coagula-
tion (DIC). The normal hematocrit levels in pregnancy 
may be as low as 33% (non pregnant female hematocrit 
is about 38%) [12]. As there is a physiological increase 
in the intravascular volume in the third trimester, the 
identification of plasma leakage syndrome through 
hemoconcentration or hypoproteinemia may be com-
promised which may under estimate the proportion of 
dengue haemorrhagic fever in pregnant women. There 
is increased risk of hemorrhage (maternal and fetal), 
pre eclampsia, miscarriages, fetal anomalies, low birth 
weight, premature births, increased rate of cesarean 
sections, increased maternal and fetal mortality and a 
risk of vertical transmission of dengue infection in preg-
nancy [13, 14].
Our patient is the first reported pregnant mother to 
suffer from dengue encephalopathy in the Indian sub-
continent. Interestingly, the transient neurological 
deterioration spontaneously improved with the rise in 
platelet counts. This also raises the question of whether 
an immuno tolerant state such as pregnancy predisposes 
more to dengue encephalopathy/encephalitis.
In our patient, the suspicion of dengue encephalopa-
thy was crucial for optimum monitoring and manage-
ment to prevent adverse outcomes to both mother and 
fetus, although we were unable to confirm it with a CSF 
study. The current WHO guidelines do not elaborate on 
the clinical and hematological monitoring and fluid man-
agement of dengue infection in term pregnancy. More 
evidence based and multidisciplinary based studies are 
strongly and urgently indicated to decide on the diagno-
sis, value of CSF study, optimal fluid management with 
regard to dengue encephalopathy in a term pregnancy. 
The guidelines to determine the precise timing and mode 
of delivery for term mothers suffering dengue infection 
are essential to facilitate management and to prevent 
adverse outcomes.
Conclusions
Dengue encephalopathy is a rare phenomenon compli-
cating term pregnancy. This paper emphasizes on the 
hurdles of diagnosis and management of dengue fever in 
a term pregnancy, which definitely needs special atten-
tion. Further case reports and studies are mandatory to 
evaluate the exact magnitude and outcome of this clini-
cal scenario as evidence-based data in the pathogenesis, 
diagnosis and the management of dengue encephalopa-
thy in pregnancy is sparse.
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